June 23, 2020 / 1:26 PM / 23 days ago

BRIEF-CMA ot To Refer Pharmacare/Haliborange Merger To A Phase 2 Probe

June 23 (Reuters) - UK’s Competition and Markets Authority:

* CMA - DECIDED, ON INFORMATION CURRENTLY AVAILABLE TO IT, NOT TO REFER PHARMACARE/HALIBORANGE MERGER TO A PHASE 2 INVESTIGATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below